SalinasS., BilslandL.G., HenaffD., et al. (2009). CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathogens, 5, e1000442.
2.
SeiradakeE., HenaffD., WodrichH., et al. (2009). The cell adhesion molecule CAR and sialic acid on human erythrocyte influence adenovirus biodistribution. PLoS Pathogens, 5, e1000277.
3.
BruT., SalinasS., and KremerE.J. (2010). An update on canine adenovirus type 2 and its vectors. Viruses, 2, 2134–2153.
4.
SalinasS., SchiavoG., and KremerE.J. (2010). A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat. Rev. Microbiol., 8, 645–655.
5.
SeguraM.M., MonfarM., PuigM., et al. (2010). A real-time PCR assay for quantification of canine adenoviral vectors. J. Virol. Methods, 163, 129–136.
6.
WodrichH., HenaffD., JammartB., et al. (2010). A capsid encoded PPxY motif facilitates adenovirus entry. PLoS Pathogens, 6, e1000808.
7.
HenaffD., SalinasS., and KremerE.J. (2011). An adenovirus traffic update: from receptor engagement to the nuclear pore. Fut. Microbiol., 6, 179–192.
8.
BritoC., SimãoD., CostaI., et al. (2012). 3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. Methods, 56, 452–460.
9.
FernandesP., PeixotoC., SantiagoV.M., et al. (2012). Bioprocess development for CAV-2 vectors. Gene Ther., 20, 353–360.
10.
LauA.A., RozaklisT., IbanesS., et al. (2012). Helper-dependent CAV-2 vector-mediated transgene expression in a neurodegenerative lysosomal storage disorder. Gene, 491, 53–57.
11.
SeguraM.M., PuigM., MonfarM., et al. (2012). Chromatography purification of canine adenoviral vectors. Hum. Gene Ther. Methods, 23, 182–197.
12.
ArizaL., Giménez-LlortL., CubizolleA., et al. (2013). CNS delivery of helper-dependent canine adenovirus corrects neuropathology and behaviour in MPS VII mice. Hum. Gene Ther., 25, 199–211.
13.
CotsD., BoschA., and ChillónM. (2013). Helper-dependent adenovirus vectors: progress and future prospects. Curr. Gene Ther., 13, 370–381.
14.
CubizolleA., SerratriceN., SkanderN., et al. (2013). Corrective GUSB transfer to the canine MPS VII brain. Mol. Ther., 22, 762–773.
15.
FernandesP., SantiagoV.M., RodriguesA.F., et al. (2013). Impact of E1 and Cre on CAV-2 vector amplification: developing MDCK-E1 and E1-Cre transcomplementing cell lines. PLoS One, 8, e60342.
16.
IbanesS., and KremerE.J. (2013). Canine adenovirus type 2 vector generation via I-Sce1-mediated intracellular genome release. PLoS One, 8, e71032.
17.
PiersantiS., AstrologoL., LicursiV., et al. (2013). Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles. PLoS One, 8, e69808.
18.
SalinasS., ZussyC., LoustalotF., et al. (2013). Disruption of the coxsackievirus and adenovirus receptor-homodimeric interaction triggers lipid microdomain- and dynamin-dependent endocytosis and lysosomal targeting. J. Biol. Chem., 289, 680–695.
19.
ZussyC., and SalinasS. (2013). Study of adenovirus and CAR axonal transport in primary neurons. Methods Mol. Biol., 1089, 71–78.
20.
MiravetS., OntiverosM., PiedraJ., et al. (2014). Construction, production, and purification of recombinant adenovirus vectors. Methods Mol. Biol., 1089, 159–173.
21.
PiersantiS., TagliaficoE., and SaggioI. (2014). DNA microarray to analyse adenovirus-host interactions. Methods Mol. Biol., 1089, 89–104.
